Reeder-Hayes KE, Mayer SE, Olshan F, et al. - Given that black women have worse breast cancer survival after controlling for baseline disease factors, researchers investigated if treatment differences contribute to their poorer outcomes. They conducted phase 3 of the Carolina Breast Cancer Study including black women (n = 1,328) and white women (n = 1,331) with stage I to III disease whose treatment included surgery with or without adjuvant therapies. More often delayed treatment initiation and longer treatment duration, were noted among black women than whites receiving similar treatment. In fully adjusted analyses, blacks vs whites showed 1.73 times higher odds of treatment initiation more than 60 days after their diagnosis. Timely delivery of care may improve with interventions that target access barriers.